Millennium Management’s Inhibrx INBX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$22M Buy
327,860
+51,943
+19% +$3.85M 0.01% 1467
2025
Q4
$21.8M Sell
275,917
-21,903
-7% -$1.49M 0.01% 1504
2025
Q3
$10M Buy
297,820
+22,042
+8% +$543K ﹤0.01% 2380
2025
Q2
$3.94M Buy
275,778
+20,442
+8% +$264K ﹤0.01% 3236
2025
Q1
$3.57M Sell
255,336
-3,052
-1% -$41.4K ﹤0.01% 3197
2024
Q4
$3.98M Sell
258,388
-30,973
-11% -$472K ﹤0.01% 3026
2024
Q3
$4.53M Sell
289,361
-13,835
-5% -$194K ﹤0.01% 2928
2024
Q2
$4.3M Buy
+303,196
New +$4.74M ﹤0.01% 2862

Other funds holding INBX

Millennium Management's INBX Position: Q1 2026 in Review

Millennium Management increased its Inhibrx (INBX) stake by 19% in Q1 2026, buying an estimated $3.85M and bringing the position to 327,860 shares worth $22M. The position accounts for 0.01% of the portfolio, ranked #1467.

Millennium Management first reported a position in INBX in Q2 2024 and has held it in 8 quarters since. 135 funds tracked by Wall St. Rank hold INBX as of Q1 2026.

  • Millennium Management held 327,860 shares of Inhibrx worth $22M as of Q1 2026.
  • Millennium Management bought 51,943 Inhibrx shares in Q1 2026, an estimated $3.85M.
  • Inhibrx made up 0.01% of Millennium Management's portfolio in Q1 2026, its #1467 holding.
  • Millennium Management first reported a position in Inhibrx in Q2 2024 and has held it in 8 quarters since.
  • 135 funds tracked by Wall St. Rank held Inhibrx as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.